Skip to main content

Integra Lifesciences Holdings Corp

IART
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000917520

No open-market purchases or sales by Integra Lifesciences Holdings Corp insiders were filed in the last 90 days; 212 institutions reported holding it in 13F filings for Q2 2026, worth $1.32B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Integra Lifesciences Holdings Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Integra Lifesciences Holdings Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Integra Lifesciences Holdings Corp
NameTitleLast reported holdingLast filingFilings, past year
Veillon-Berteloot ChantalEVP & CHRO20,772Sep 4, 20262
Mosebrook JeffreySVP, Fin & Princ Acct Officer34,516Jul 6, 20262
Singh HarvinderEVP & President, SS35,422Jul 6, 20263
Davis Robert T. Jr.EVP & President, TR&DT66,387Jul 6, 20262
Knight Lea DanielsEVP & Chief Financial Officer45,263Jul 6, 20262
Essig StuartPresident and CEO200,000IndirectJun 3, 20261
McBreen Michael J.EVP & Chief Commercial Officer60,743Jun 3, 20262
Bradley KeithDirector88,254May 11, 20261
Schade Christian SDirector90,034May 11, 20261
Hill Barbara BDirector151,191May 11, 20261
Graves Jeffrey ADirector41,086May 11, 20262
Clay ShaundraDirector41,515May 11, 20261
Lo Renee WonlaiDirector35,743May 11, 20261
Hutchinson Michael DamonEVP, Chief Legal Officer & Sec–Mar 12, 20262
Poul MojdehPresident & CEO0Mar 12, 20262
Schwartz EricEVP, Chief Legal Officer & Sec56,020Mar 13, 20250
De Witte JanPresident & CEO23,902Nov 4, 20240
Murphy Raymond G.Director54,007May 13, 20240
Evoli LisaEVP & CHRO18,446Mar 14, 20230
Coleman GlennExecutive Vice President & COO34,622Jul 5, 20220
Anderson Carrie LExecutive Vice President & CFO57,811Jul 5, 20220
Morel Donald E JrDirector55,753May 17, 20220
Tru St Partnership, L.P.10% Owner8,515,930Mar 25, 20220
Arduini Peter JPresident & CEO216,713Sep 7, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 6, 2025 (view filing)Nov 51 dayGraves Jeffrey ADirectorPPurchase+9.00K$11.35+$102.2K+28.0%41.1K after
Dec 4, 2024 (view filing)Dec 31 daySchwartz EricEVP, Chief Legal Officer & SecSSale−4.07K$24.60−$100.1K−6.4%59.5K after
Dec 3, 2024 (view filing)Dec 21 dayMcBreen Michael J.EVP & President, CSSSSale−1.70K$24.16−$41.1K−2.9%56.2K after
Aug 20, 2024 (view filing)Aug 191 dayMosebrook JeffreySVP, Fin & Princ Acct OfficerSSale−1.19K$21.58−$25.7K−3.2%36.1K after
May 24, 2024 (view filing)May 231 dayEssig StuartExec. Chairman of the BoardPPurchase+52.6K$28.49+$1.50M+12.1%487.9K after
May 22, 2024 (view filing)May 211 dayHill Barbara BDirectorPPurchase+36.4K$27.40+$996.0KNew position36.4K after
Mar 8, 2024 (view filing)Mar 62 daysDavis Robert T. Jr.EVP & President, TTSSale−8.35K$36.59−$305.5K−14.3%49.9K after
Aug 10, 2023 (view filing)Aug 91 dayMosebrook JeffreySVP, Fin & PAOSSale−1.18K$44.46−$52.3K−4.8%23.5K after
Jun 5, 2023 (view filing)Jun 14 daysSchwartz EricEVP, Chief Legal Officer & SecPPurchase+2.64K$37.89+$100.0K+5.7%48.6K after
Jun 2, 2023 (view filing)Jun 11 dayDe Witte JanPresident & CEOPPurchase+7.79K$38.50+$300.0K+155.7%12.8K after
Mar 8, 2023 (view filing)Mar 71 dayMcBreen Michael J.EVP & President, CSSSSale−1.84K$54.29−$100.1K−6.0%28.8K after
Mar 3, 2023 (view filing)Mar 12 daysDavis Robert T. Jr.EVP & President, TTSSale−1.57K$55.21−$86.5K−3.3%45.9K after
Feb 28, 2023 (view filing)Feb 271 dayEvoli LisaEVP & CHROSSale−3.77K$57.00−$214.7K−16.8%18.6K after
Dec 8, 2022 (view filing)Dec 8Same dayMosebrook JeffreySVP, Fin & Princ Acct OfficerSSale−279$56.22−$15.7K−3.2%8.55K after
Aug 11, 2022 (view filing)Aug 101 dayEvoli LisaExecutive Vice President &CHROSSale−1.17K$55.81−$65.0K−6.1%18.0K after
Aug 8, 2022 (view filing)Aug 53 daysMurphy Raymond G.DirectorSSale−8.00K$55.78−$446.2K−16.4%40.8K after
Aug 3, 2022 (view filing)Aug 21 dayMosebrook JeffreySVP, Fin & Princ Acct OfficerSSale−437$56.78−$24.8K−4.7%8.83K after
Jun 16, 2022 (view filing)Jun 151 dayEvoli LisaExecutive Vice President &CHROSSale−900$55.93−$50.3K−4.3%19.9K after
May 25, 2022 (view filing)May 241 dayEvoli LisaExecutive Vice President &CHROSSale−250$59.85−$15.0K−1.2%20.8K after
Apr 6, 2022 (view filing)Apr 42 daysColeman GlennExecutive Vice President & COOSSale−6.27K$66.04−$413.9K−13.2%41.3K after
Mar 25, 2022 (view filing)Dec 16, 2021-Mar 23, 202299 daysLateTru St Partnership, L.P.10% OwnerSSale−300.0K$64.86−$19.5M−3.4%8.52M after3 lots
Mar 1, 2022 (view filing)Feb 281 dayEvoli LisaExecutive Vice President &CHROSSale−1.25K$67.03−$84.1K−8.2%14.1K after
Nov 19, 2021 (view filing)Nov 181 dayTru St Partnership, L.P.10% OwnerSSale−75.0K$68.59−$5.14M−0.8%8.82M after
Nov 12, 2021 (view filing)Nov 102 daysMosebrook JeffreySVP, Fin & Princ Acct OfficerSSale−700$70.88−$49.6K−10.4%6.01K after
Nov 8, 2021 (view filing)Nov 53 daysMcBreen Michael J.EVP & President, CSSSSale−3.45K$71.59−$247.0K−26.2%9.74K after
Nov 3, 2021 (view filing)Nov 21 dayColeman GlennExecutive Vice President & COOSSale−4.28K$74.00−$316.4K−13.3%27.8K after
Oct 27, 2021 (view filing)Oct 207 daysLateTru St Partnership, L.P.10% OwnerSSale−200.0K$69.81−$14.0M−2.2%8.89M after
Sep 7, 2021 (view filing)Sep 2-35 daysArduini Peter JPresident & CEOSSale−118.4K$75.88−$8.99M−35.3%216.7K after2 lots
Aug 10, 2021 (view filing)Aug 64 daysMcBreen Michael J.EVP & President, CSSSSale−4.00K$71.22−$284.9K−23.3%13.2K after